-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -1,89 % | 4,42 % | 31,98 % | -4,59 % | 28,71 % | 145,28 % | - |
| Larimar Therapeutics Inc. | -0,72 % | -2,82 % | -14,81 % | -10,97 % | -16,87 % | -33,97 % | -82,79 % |
| Vaxart Inc. | -10,00 % | -25,00 % | 60,14 % | -36,44 % | 60,71 % | -57,84 % | -92,31 % |
News
Why the iShares Semiconductor ETF (SOXX) Jumped 40% in 2025
Shares of the iShares Semiconductor ETF (NASDAQ: SOXX) were soaring last year, reflecting the continuing AI boom, and gains in top members like Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ:
Why Global X Artificial Intelligence and Technology ETF (AIQ) Jumped 31% in 2025
Artificial intelligence (AI) stocks soared last year, and exchange-traded funds (ETFs) that focus on AI stocks jumped as well.
One of those ETFs was the Global X Artificial Intelligence and
Why This Stock's Recent Weakness Could Be a Gift for Patient Investors
It's easy to hold a growth stock and feel good about it when that asset is outperforming the S&P 500. However, corrections can test an investor's patience and cause people to exit great companies


